GuideNephrology

Risk of acute kidney injury or hyperkalaemia when starting an NSAID in older adults

Reading sheet on the Nash et al. model estimating 30-day risk of AKI or hyperkalaemia after starting an NSAID in people aged 66 or older.

Updated 3 November 2026

When to use it

People aged 66 or older being considered for an NSAID prescription, to individualise the decision and laboratory monitoring.

What it is

Population-based Ontario study (2007–2015) that matched 46,107 new NSAID users aged 66 or older with 46,107 non-users. NSAIDs were associated with more 30-day AKI (OR 1.41) and hyperkalaemia (OR 1.50; risk difference 0.23%), without increased mortality. A prediction model was built from these data.

Keep reading in the app

  • Predictors
  • Performance and interpretation
  • Limitations

Practical tip

Mean absolute risk is low (AKI 0.82% vs 0.59% without NSAID at 30 days), but it concentrates in patients with low eGFR, high potassium and kidney-acting drugs.

2 more practical tips in the app.

Reference

A support tool for healthcare professionals: it guides and does not replace clinical judgement.

Back to top